V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001757 | 330006545 | null | 76.6 | Curative (C) | 2013-12-08 | 2013-12-08 | STS Rhabdo RMS 2005 | Y | Y | 330005950 | NOT MATCHED |
| 330001758 | 330001005 | 1.6 | 96 | Curative (C) | 2017-09-18 | 2017-10-09 | Cisplatin | N | Y | 330005956 | CISPLATIN |
| 330001759 | 330001005 | 1.78 | 81 | Not known (9) | 2016-10-26 | 2016-10-26 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330005956 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001762 | 330001007 | 1.62 | 7.26 | null | 2015-06-10 | 2015-06-17 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330005964 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001763 | 330006548 | 1.58 | 68 | Adjuvant (A) | 2014-09-27 | 2014-09-28 | Cisplatin 7 day | N | N | 330005965 | CISPLATIN |
| 330001764 | 330006548 | 0 | 61.3 | Curative (C) | 2016-12-10 | 2016-12-11 | Trial Unspecified | Y | N | 330005965 | TRIAL |
| 330001765 | 330006548 | 0 | null | Disease modification (D) | 2016-07-15 | 2016-07-20 | CNS GCT II Non Germin - Std PEI | 1 | N | 330005965 | NOT MATCHED |
| 330001766 | 330001008 | null | 48.8 | Curative (C) | 2013-11-05 | 2013-11-05 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330005981 | NOT MATCHED |
| 330001767 | 330006549 | 1.78 | 59.4 | Adjuvant (A) | null | 2017-03-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005985 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001768 | 330006549 | 1.7 | 64.9 | Neo-adjuvant (N) | 2013-11-06 | 2013-11-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005985 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001769 | 330006549 | 1.81 | 86.6 | Curative (C) | null | 2014-09-16 | Trial Unspecified | 01 | null | 330005985 | TRIAL |
| 330001770 | 330006549 | 1.67 | 98 | Neo-adjuvant (N) | 2016-05-30 | 2016-06-14 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005985 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001771 | 330006549 | 1.46 | 8.4 | Curative (C) | null | 2014-08-23 | Cisplatin | N | Y | 330005985 | CISPLATIN |
| 330001772 | 330001009 | 1.84 | 47.7 | Curative (C) | 2014-03-29 | 2014-03-29 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330006003 | NOT MATCHED |
| 330001773 | 330001009 | 1.5 | 94.6 | Curative (C) | 2017-01-18 | 2017-02-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330006003 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001774 | 330001010 | 0 | 14.6 | Palliative (P) | 2016-11-26 | 2016-12-07 | EW EuroEwing 2012 Arm B VDC | 01 | Y | 330006005 | TRIAL |
| 330001775 | 330001011 | 1.85 | 45.7 | Neo-adjuvant (N) | 2014-10-25 | 2014-10-30 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330006006 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001776 | 330001012 | 1.67 | 55 | Palliative (P) | 2016-09-01 | 2016-09-05 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330006008 | TRIAL |
| 330001777 | 330001013 | 1.58 | 9.1 | null | 2016-10-25 | 2016-11-21 | Cisplatin 7 day | Y | Y | 330006011 | CISPLATIN |
| 330001778 | 330001014 | 1.65 | 91.7 | Curative (C) | 2013-11-22 | 2013-11-24 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 330006015 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001779 | 330001015 | null | 67.8 | Neo-adjuvant (N) | 2015-08-07 | 2015-08-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330006016 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001780 | 330001015 | null | 65.9 | Curative (C) | 2015-09-17 | 2015-09-22 | CNS LGG2004 03 vinc + carbo | Y | N | 330006016 | NOT MATCHED |
| 330001781 | 330001016 | null | 114 | Curative (C) | 2017-03-31 | 2017-04-20 | Cisplatin | N | Y | 330006022 | CISPLATIN |
| 330001782 | 330001017 | null | 53.1 | Neo-adjuvant (N) | 2017-03-02 | 2017-03-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330006023 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001783 | 330001018 | 1.52 | 16.1 | Curative (C) | 2016-09-13 | 2016-09-13 | Trial Unspecified | 2 | Y | 330006026 | TRIAL |
| 330001784 | 330001018 | 1.7 | 68 | Curative (C) | null | 2013-10-07 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330006026 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001785 | 330001018 | 1.69 | 72.8 | Not known (9) | null | 2016-10-04 | Trial Unspecified | N | N | 330006026 | TRIAL |
| 330001786 | 330001018 | 1.63 | null | Curative (C) | 2015-09-20 | 2015-09-20 | Cisplatin 7 day | N | Y | 330006026 | CISPLATIN |
| 330001787 | 330001019 | 1.05 | 12.2 | Curative (C) | 2014-04-03 | 2014-04-07 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330006041 | NOT MATCHED |
| 330001788 | 330001020 | 1.89 | 76.9 | Curative (C) | 2013-09-28 | 2013-10-04 | Cisplatin 7 day | N | Y | 330006042 | CISPLATIN |
| 330001789 | 330001020 | 0 | null | Curative (C) | 2013-08-09 | 2013-08-20 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330006042 | TRIAL |
| 330001792 | 330001022 | 1.59 | 83.8 | Curative (C) | 2016-05-07 | 2016-05-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330006053 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001793 | 330001022 | 1.6 | 8.6 | Neo-adjuvant (N) | 2013-06-10 | 2013-06-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330006053 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001794 | 330001023 | 1.5 | 62.5 | Neo-adjuvant (N) | 2014-02-13 | 2014-02-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330006059 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001795 | 330001023 | 1.61 | 71 | Neo-adjuvant (N) | 2015-07-06 | 2015-07-20 | Cisplatin 7 day | N | Y | 330006059 | CISPLATIN |
| 330001796 | 330001023 | 1.76 | 83 | Neo-adjuvant (N) | 2017-10-29 | 2017-10-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330006059 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001797 | 330001023 | 1.6 | 13 | Neo-adjuvant (N) | 2014-03-21 | 2014-04-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330006059 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001798 | 330001024 | 1.79 | 70 | Neo-adjuvant (N) | 2016-02-24 | 2016-02-27 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330006138 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001799 | 330001024 | null | 114 | Neo-adjuvant (N) | 2014-03-08 | 2014-03-08 | EW EuroEwing 2012 Arm A VAC | Y | N | 330006138 | NOT MATCHED |
| 330001800 | 330009541 | 1.22 | 55 | Curative (C) | 2013-11-18 | 2013-11-23 | NB HRNBL-1 TVD | N | N | 330006431 | NOT MATCHED |
| 330001801 | 330001025 | 1.76 | 72.8 | Curative (C) | 2013-07-16 | 2014-01-16 | Cisplatin | N | Y | 330006497 | CISPLATIN |
| 330001802 | 330001025 | 1.51 | null | Neo-adjuvant (N) | 2013-11-05 | 2013-11-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330006497 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001803 | 330001026 | 1.72 | null | null | 2013-07-15 | 2013-07-19 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 330006669 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001804 | 330001027 | null | 88 | Curative (C) | 2016-12-10 | 2016-12-10 | WT SIOP 2002 01 post op Carbo, Etop | Y | N | 330006779 | NOT MATCHED |
| 330001805 | 330001028 | 1.8 | null | Neo-adjuvant (N) | 2014-04-09 | 2014-04-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330006926 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001806 | 330001029 | 1.7 | null | Adjuvant (A) | 2013-10-03 | 2013-10-31 | Cisplatin | N | N | 330007038 | CISPLATIN |
| 330001807 | 330001030 | null | 76 | Curative (C) | 2017-10-16 | 2017-10-24 | NB HRNBL | N | N | 330007126 | NOT MATCHED |
| 330001808 | 330006559 | 1.7 | 64 | Not known (9) | 2016-08-30 | 2016-09-13 | Cisplatin | N | Y | 330007135 | CISPLATIN |
| 330001809 | 330001031 | null | null | Curative (C) | 2016-11-04 | 2016-11-08 | NB HRNBL-1 COJEC Ind COURSE A | Y | null | 330007179 | NOT MATCHED |
| 330001810 | 330001032 | 1.62 | 42 | Neo-adjuvant (N) | 2017-08-18 | 2017-08-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007182 | CISPLATIN + DOCETAXEL + FLUOROURACIL |